Fierce JPM Week 2021 is set to take place January 11 through January 13 in a virtual format and will host cutting-edge panels that explore biopharma's ongoing work to combat COVID-19 while continuing to develop medicines to fight all diseases including cancer. We are pleased to announce TD2’s Vice President of Site Engagement and Network Strategy, Susan S. Night, together with Viecure’s Chief Scientific Officer, Ph.D., Fred Ashbury, will be presenting “Data driven clinical solutions to enhance cancer patient outcomes” at 2:00 PM EST / 11 AM PT on Monday, January 11.   The presentation will focus on the optimization of clinical trials in the community setting by leveraging cutting edge technology and tools to enhance patient outcomes.

During the conference, our team will be available via video conferencing to discuss your needs and the diverse solutions we offer. For additional details, please contact Vice President of Sales, Marc Appelbaum at mappelbaum@td2inc.com.

We look forward to seeing everyone at the Fierce JPM week 2021 and changing the way you think about the drug development process.